Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
Tinnitus Severity Linked to Mood, Sleep, and Personality
Tinnitus affects approximately 10 percent of the U.S. adult population and 14 percent of the world’s population (NIDCD, 2025). Tinnitus can sound different to individuals,…
Academy Board of Directors Meets with Lawmakers During Government Shutdown
On October 23, the Academy Board of Directors held a successful Hill Day in Washington, D.C. amid the federal government shutdown. The Academy is deeply…
Influence of the Electrical Dynamic Range (EDR) on Speech Perception, Vocabulary, and Quality of Life in Young Children
A person’s electrical dynamic range (EDR) in a cochlear implant (CI) is defined as the difference between the highest tolerable current level, without discomfort or…


